Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of PROLOR Biotech, Inc. (“PROLOR” or Company) (PBTH) to OPKO Health, Inc. Under the terms of the proposed deal, PROLOR shareholders will only receive 0.9951 shares of OPKO stock for each PROLOR stock they own. The transaction values PROLOR stock at approximately $7.025 per share. Yet, analysts have recently set PROLOR’s true value as high as $10.00 to $12.00 per share.
If you are an affected investor, and you want to learn more about the lawsuit or join the action, please contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 239-4568, via email at WBriscoe@TheBriscoeLawFirm.com or Zach Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at email@example.com. There is no cost or fee to you.
The PROLOR sale investigation centers on whether the Company’s shareholders are receiving adequate compensation for their shares in the proposed acquisition, whether the transaction undervalues PROLOR’s stock, and whether PROLOR’s board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal.
The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.